“Validity and Reability Test of the Naranjo Questionnaire to Measure Adverse Drug Reactions (ADRs) in Atherosclerosis Patients”, B.J, vol. 4, no. 2, pp. 43–50, Apr. 2026, doi: 10.30812/biocity.v4i2.5842.